BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04305041-completion@plaintrial.com
DTSTAMP:20261029T024257Z
DTSTART;VALUE=DATE:20250825
SUMMARY:Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination W
 ith Investigational Agents in Participants With Programmed Cell-death 1 (P
 D-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02) — estimated completi
 on date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT04305041
URL:https://plaintrial.com/trial/NCT04305041
END:VEVENT
END:VCALENDAR